type 2 diabetes

Overview

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, impaired glucose homeostasis, and a progressive decline in pancreatic β-cell function. This condition leads to elevated blood glucose levels and is associated with various complications, including cardiovascular disease, neuropathy, and kidney dysfunction. The pathophysiology of T2DM involves complex interactions between genetic predisposition, lifestyle factors, and environmental influences, such as diet and physical activity. Pharmacological interventions, including glucagon-like peptide-1 (GLP-1) receptor agonists and sodium-glucose cotransporter-2 (SGLT2) inhibitors, have been developed to improve glycemic control and mitigate the risk of associated complications.

Focus of Latest Publications

Recent publications on type 2 diabetes have focused heavily on prevention, risk prediction, and individualized management. Several studies examined lifestyle-related exposures and screening tools, including sugar-sweetened and non-sugar sweetened beverages and their substitution patterns, waist circumference and grip strength, daily step counts combined with polygenic risk, and a revised FINDRISC incorporating sociodemographic indicators. Other work explored whether data-driven thresholds from wearable device data, including continuous glucose monitor outputs, may outperform fixed cutoffs in diverse populations, with type 2 diabetes included among the comparison groups. Across these studies, the main emphasis was on improving risk stratification and identifying more informative predictors of incident disease.

A second cluster of publications addressed interventions aimed at weight loss, glycaemic improvement, and remission. These included a multicentre machine-learning model to predict postoperative body mass index trajectories and long-term type 2 diabetes remission after metabolic bariatric surgery, a fully subsidized behavioral weight management program for adults with type 2 diabetes or prediabetes, a culinary medicine intervention in patients with type 2 diabetes and elevated body mass index, and an integrated lifestyle intervention combining calorie-carbohydrate restriction with or without time-restricted feeding in the DIREM trial. A case series also described type 2 diabetes remission or glycaemic improvement in gynaecologic oncology patients undergoing an acute preoperative weight loss protocol. These publications collectively highlight growing interest in structured lifestyle and surgical approaches, as well as in predicting who is most likely to benefit.

Other studies examined biological, social, and health-system determinants of type 2 diabetes. One Mendelian randomisation analysis investigated causal associations between DNA methylation markers and type 2 diabetes in West African populations, while another study reported a U-shaped association between blood mtDNA copy number and incident type 2 diabetes. Health literacy profiles among people living with type 2 diabetes were characterized to inform tailored interventions, and socioeconomic deprivation was evaluated as an added predictor of diabetes development in youth with prediabetes. Additional work assessed the prevalence, diagnostic coverage, treatment, and glycaemic control of type 2 diabetes in Cambodia, and estimated the costs and health benefits of optimizing care for uncomplicated type 2 diabetes in Lagos, Nigeria.

Economic and implementation-focused studies also featured prominently. Investigators assessed the economic burden of type 2 diabetes management in France according to clinical characteristics, and another study evaluated the costs and benefits of optimizing care in a real-world setting in Nigeria. Together, these publications suggest that current research on type 2 diabetes is increasingly centered on precision prevention, remission-oriented interventions, and the practical challenges of delivering effective care across diverse populations and health systems.

Key Publications

• NEWJul Consumption of sugar-sweetened beverages, non-sugar sweetened beverages, and their substitution and risk of type 2 diabetes: the HELIUS study. (European journal of nutrition, 2026, PMID 42397572): "This study aimed to investigate the association between the intake of SSB and NSSB, their substitutions with each other, and T2D risk."
• NEWJul Development of a predictive model for postoperative body mass index and diabetes outcomes after metabolic bariatric surgery: retrospective cohort study. (BJS open, 2026, PMID 42398077): "Predicting postoperative body mass index (BMI) trajectories and long-term type 2 diabetes (T2D) remission after bariatric surgery remains challenging."
• NEWJul Beyond Fixed Thresholds: Optimizing Summaries of Wearable Device Data via Piecewise Linearization of Quantile Functions. (Statistics in medicine, 2026, PMID 42380066): "Applications to CGM datasets from diverse populations, including individuals with type 1 diabetes, type 2 diabetes, and normal glycemic control, demonstrate that data-driven thresholds vary by population, improve discriminative power, and yield stronger associations with clinical variables over fixed thresholds."
• May The effects of a fully subsidized behavioral weight management program among healthcare workers with pre-diabetes and diabetes. (BMC public health, 2026, PMID 42157166): "...among adults with type 2 diabetes or prediabetes enrolled in the 1199SEIU Benefit Funds..."
• May Impact of a culinary medicine intervention on diet and health metrics in patients with type 2 diabetes and elevated body mass index. (PloS one, 2026, PMID 42160272): "Impact of a culinary medicine intervention on diet and health metrics in patients with type 2 diabetes and elevated body mass index."
• May Type 2 diabetes remission in gynaecologic oncology patients completing an acute preoperative weight loss protocol: a case series. (Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology, 2026, PMID 42145191): "The objective of this study was to review type 2 diabetes (T2D) remission and glycaemic improvement in gynaecologic oncology patients with class 3 obesity undergoing preoperative weight loss."
• May Associations of childhood exposure to interparental physical violence and verbal conflict with the risk of adult-onset diabetes. (Journal of global health, 2026, PMID 42138262): "the associations of childhood exposure to interparental physical violence and verbal conflict with the risk of adult-onset diabetes remain unclear."
• May Health literacy profiles of people living with type 2 diabetes: a cluster-based approach to inform tailored interventions-the Entred 3 study. (BMJ open diabetes research & care, 2026, PMID 42120100): "We identified multidimensional health literacy profiles among adults living with type 2 diabetes (T2D) in France and described their clinical, behavioral and social characteristics with a view to informing future tailored interventions."
• May Waist circumference and grip strength and their joint relations to type 2 diabetes incidence in UK Biobank. (BMC medicine, 2026, PMID 42098747): "Waist circumference and grip strength are each associated with type 2 diabetes (T2D) risk, but their joint associations have been less well studied."
• May Optimising care for uncomplicated type 2 diabetes mellitus in Lagos, Nigeria: cost and benefit estimates using real-world data. (BMJ global health, 2026, PMID 42086296): "This study explores the potential costs and health benefits of optimising care for uncomplicated type 2 diabetes in Lagos State, Nigeria."